ClinicalTrials.Veeva

Menu

Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)

University of British Columbia logo

University of British Columbia

Status and phase

Completed
Phase 4

Conditions

Asthma and/or Exercise Induced Bronchoconstriction
Ozone Air Pollution

Treatments

Drug: Placebo medication
Other: Exercise
Drug: Salbutamol
Other: Filtered Air
Other: Ozone

Study type

Interventional

Funder types

Other

Identifiers

NCT05087693
H21-01080

Details and patient eligibility

About

Salbutamol use is increased in areas with high levels of ozone pollution and the potential consequences of this are not well known. The purpose of this study is to examine the effect of salbutamol on lung function and inflammation in people with asthma and/or EIB exercising in ozone air pollution. To examine this, we are planning a randomized cross over trial where people with asthma and/or EIB complete sub maximal exercise in four conditions on four separate days. The four condition are: ozone + salbutamol, filtered air + salbutamol, ozone + placebo medication, and filtered air + placebo medication.

Enrollment

18 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have asthma and/or EIB
  • Able to perform maximal exercise
  • Able to communicate sufficiently using the English language

Exclusion criteria

  • Allergic to salbutamol (also known as Ventolin)
  • Pregnant or potentially pregnant
  • Have a history of smoking
  • Had an upper respiratory tract infection within the last 4 weeks
  • Have a chronic respiratory disease other than asthma or EIB

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

18 participants in 4 patient groups, including a placebo group

Exercising in ozone following salbutamol inhalation
Experimental group
Description:
Participants will be doing sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling 170ppb ozone after inhaling 200ug of salbutamol.
Treatment:
Other: Ozone
Drug: Salbutamol
Other: Exercise
Exercising in filtered air following salbutamol inhalation
Active Comparator group
Description:
Participants will be doing sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling filtered air after inhaling 200ug of salbutamol.
Treatment:
Other: Filtered Air
Drug: Salbutamol
Other: Exercise
Exercising in ozone following placebo inhalation
Placebo Comparator group
Description:
Participants will be doing sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling 170ppb ozone after inhaling placebo medication.
Treatment:
Other: Ozone
Other: Exercise
Drug: Placebo medication
Exercising in filtered air following placebo inhalation
Placebo Comparator group
Description:
Participants will be doing sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling filtered after inhaling placebo medication.
Treatment:
Other: Filtered Air
Other: Exercise
Drug: Placebo medication

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Ben Stothers, BKIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems